Mike Guerra (CLS) and Susan Bonilla (CPhA) Joint Statement on PBM Reform
September 12, 2024
CMS Issues TCET Final Notice
August 8, 2024
CMS announced its final notice for the Transitional Coverage for Emerging Technologies (TCET) pathway, which would expedite Medicare coverage of...
Read More
Survey Assessing the Environment for Developing Treatments for Rare Diseases
August 7, 2024
In partnership with the Save Rare Treatments Task Force, CLS is conducting a survey of our membership to gather feedback...
Read More
CLS Response to House RFI on 21st Century Cures Initiative
August 7, 2024
CLS has prepared comments in response to Reps. DeGette’s (D-CO) and Bucshon’s (R-IN) Request for Information on the next iteration of...
Read More
CLS Comments on NIH Proposed Policy That Would Require Access Plans in Licensing Agreements
July 24, 2024
CLS has prepared comments in response to NIH’s proposed policy that would make licensing agreements for NIH owned inventions conditional...
Read More